(SEATTLE), March 02, 2021 -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced plans for the expansion of their Cell and Gene Therapy Center of Excellence in Milan, to increase capacities and implement viral vector suspension capabilities.
AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy
by David Self Published on 3/2/21 4:00 PM News
Learn More
Follow Us
Content not found